BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 31161347)

  • 1. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
    Au Yeung SL; Luo S; Schooling CM
    Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
    Au Yeung SL; Schooling CM
    BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lean mass, grip strength and risk of type 2 diabetes: a bi-directional Mendelian randomisation study.
    Yeung CHC; Au Yeung SL; Fong SSM; Schooling CM
    Diabetologia; 2019 May; 62(5):789-799. PubMed ID: 30798333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study.
    Tang B; Yuan S; Xiong Y; He Q; Larsson SC
    Diabetologia; 2020 Jul; 63(7):1305-1311. PubMed ID: 32270255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.
    Tragante V; Asselbergs FW; Swerdlow DI; Palmer TM; Moore JH; de Bakker PIW; Keating BJ; Holmes MV
    Hum Genet; 2016 May; 135(5):453-467. PubMed ID: 26946290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variants related to plasma fatty acids with type 2 diabetes mellitus and glycaemic traits: a Mendelian randomisation study.
    Yuan S; Larsson SC
    Diabetologia; 2020 Jan; 63(1):116-123. PubMed ID: 31690987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study.
    Smith ML; Bull CJ; Holmes MV; Davey Smith G; Sanderson E; Anderson EL; Bell JA
    EBioMedicine; 2023 Apr; 90():104503. PubMed ID: 36870196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study.
    Cao M; Cui B
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31614369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
    Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease.
    Ross S; Gerstein HC; Eikelboom J; Anand SS; Yusuf S; Paré G
    Eur Heart J; 2015 Jun; 36(23):1454-62. PubMed ID: 25825043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Glycated Hemoglobin (HbA
    Au Yeung SL; Luo S; Schooling CM
    Diabetes Care; 2018 Sep; 41(9):1991-1997. PubMed ID: 29950300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.
    White J; Swerdlow DI; Preiss D; Fairhurst-Hunter Z; Keating BJ; Asselbergs FW; Sattar N; Humphries SE; Hingorani AD; Holmes MV
    JAMA Cardiol; 2016 Sep; 1(6):692-9. PubMed ID: 27487401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.
    Dale CE; Fatemifar G; Palmer TM; White J; Prieto-Merino D; Zabaneh D; Engmann JEL; Shah T; Wong A; Warren HR; McLachlan S; Trompet S; Moldovan M; Morris RW; Sofat R; Kumari M; Hyppönen E; Jefferis BJ; Gaunt TR; Ben-Shlomo Y; Zhou A; Gentry-Maharaj A; Ryan A; ; Mutsert R; Noordam R; Caulfield MJ; Jukema JW; Worrall BB; Munroe PB; Menon U; Power C; Kuh D; Lawlor DA; Humphries SE; Mook-Kanamori DO; Sattar N; Kivimaki M; Price JF; Davey Smith G; Dudbridge F; Hingorani AD; Holmes MV; Casas JP
    Circulation; 2017 Jun; 135(24):2373-2388. PubMed ID: 28500271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and coronary artery disease risk: A bi-directional Mendelian randomization study.
    Au Yeung SL; Schooling CM
    Int J Cardiol; 2018 Oct; 268():222-226. PubMed ID: 30041791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study.
    Huang X; Zhao JV
    Am J Clin Nutr; 2023 Nov; 118(5):1020-1028. PubMed ID: 37640107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
    Zhao JV; Liu F; Schooling CM; Li J; Gu D; Lu X
    Diabetologia; 2022 Apr; 65(4):695-704. PubMed ID: 35080656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study.
    Xu L; Borges MC; Hemani G; Lawlor DA
    Diabetologia; 2017 Nov; 60(11):2210-2220. PubMed ID: 28889241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits.
    Lv WQ; Zhang X; Fan K; Xia X; Zhang Q; Liu HM; Jiang BY; Zhang WD; Deng HW
    Eur J Hum Genet; 2018 Oct; 26(10):1547-1553. PubMed ID: 29891878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron Status and Risk of Heart Disease, Stroke, and Diabetes: A Mendelian Randomization Study in European Adults.
    Liu Y; Clarke R; Bennett DA; Zong G; Gan W
    J Am Heart Assoc; 2024 Mar; 13(6):e031732. PubMed ID: 38497484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.